Damages Nixed In Generic Blood-Clot Drug Monopoly Suit
A hospital that indirectly purchased a generic of the blood clot drug Lovenox can request declaratory relief in a proposed class action accusing Momenta Pharmaceuticals Inc. and Sandoz Inc. of conspiring...To view the full article, register now.
Already a subscriber? Click here to view full article